Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program
Go back to Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program| (NASDAQ: SKYE) | Delayed: 0.61 -0.01 (1.61%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $ | |||
| Open | $0.61 | 52 Week Low | $ | |||
| Day High | $0.62 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $ | |||
| Volume | 192,022 | |||||
